Indication
Nosocomial pneumonia due to Escherichia coli
Nosocomial pneumonia due to *Escherichia coli* is an acute lower respiratory tract infection caused by the Gram-negative bacillus *E. Read more about Nosocomial pneumonia due to Escherichia coli
50 drugs 46 manufacturers
Drugs that treat it
Common Nosocomial pneumonia due to Escherichia coli therapies.
LEVOFLOXACIN
LEVOFLOXACIN-D5W (levofloxacin/dextrose 5 % in water)
LEVOFLOXACIN
LEVOFLOXACIN
LEVOFLOXACIN
LEVOFLOXACIN
LEVOFLOXACIN
LEVOFLOXACIN
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonNosocomial pneumonia due to *Escherichia coli* is an acute lower respiratory tract infection caused by the Gram-negative bacillus *E.
coli* that develops 48 hours or more after hospital admission, encompassing both non-ventilated hospital-acquired pneumonia and ventilator-associated pneumonia.
This condition primarily affects hospitalized adults, particularly elderly individuals, immunocompromised hosts, and critically ill patients requiring mechanical ventilation or prolonged intensive care.
Pathophysiologically, the disease typically arises from microaspiration of colonized oropharyngeal secretions or gastric refluxate, and less commonly via hematogenous seeding from an occult abdominal or urinary source.
Clinically, it is characterized by new or progressive pulmonary infiltrates on chest imaging accompanied by fever, purulent sputum production, leukocytosis, worsening oxygenation, and a notable propensity for concurrent bacteremia and multidrug resistance.
- mdsearchlight.com
Nosocomial pneumonia due to *Escherichia coli* is an acute lower respiratory tract infection caused by the Gram-negative bacillus *E. coli* that develops 48 hours or more after hospital admission, encompassing both non-ventilated hospital-acquired pneumonia and ventilator-associated pneumonia This condition primarily affects hospitalized adults, particularly elderly individuals, immunocompromised hosts, and critically ill patients requiring mechanical ventilation or prolonged intensive care
- nih.gov
Nosocomial pneumonia due to *Escherichia coli* is an acute lower respiratory tract infection caused by the Gram-negative bacillus *E. coli* that develops 48 hours or more after hospital admission, encompassing both non-ventilated hospital-acquired pneumonia and ventilator-associated pneumonia Clinically, it is characterized by new or progressive pulmonary infiltrates on chest imaging accompanied by fever, purulent sputum production, leukocytosis, worsening oxygenation, and a notable propensity f...
- nih.gov
This condition primarily affects hospitalized adults, particularly elderly individuals, immunocompromised hosts, and critically ill patients requiring mechanical ventilation or prolonged intensive care Pathophysiologically, the disease typically arises from microaspiration of colonized oropharyngeal secretions or gastric refluxate, and less commonly via hematogenous seeding from an occult abdominal or urinary source
- medlineplus.gov
This condition primarily affects hospitalized adults, particularly elderly individuals, immunocompromised hosts, and critically ill patients requiring mechanical ventilation or prolonged intensive care
- nih.gov
Pathophysiologically, the disease typically arises from microaspiration of colonized oropharyngeal secretions or gastric refluxate, and less commonly via hematogenous seeding from an occult abdominal or urinary source Clinically, it is characterized by new or progressive pulmonary infiltrates on chest imaging accompanied by fever, purulent sputum production, leukocytosis, worsening oxygenation, and a notable propensity for concurrent bacteremia and multidrug resistance
- cdc.gov
Pathophysiologically, the disease typically arises from microaspiration of colonized oropharyngeal secretions or gastric refluxate, and less commonly via hematogenous seeding from an occult abdominal or urinary source
- bmj.com
Clinically, it is characterized by new or progressive pulmonary infiltrates on chest imaging accompanied by fever, purulent sputum production, leukocytosis, worsening oxygenation, and a notable propensity for concurrent bacteremia and multidrug resistance
Personalize your experience
Follow Nosocomial pneumonia due to Escherichia coli and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.